Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis

IntroductionAsthma associated with eosinophilic granulomatosis with polyangiitis (EGPA) is often severe and corticosteroid-dependent, leading to significant morbidity. Mepolizumab and benralizumab are humanized monoclonal antibodies targeting interleukin 5 (IL-5) and its receptor, respectively. They...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Charlene Desaintjean, Kaïs Ahmad, Julie Traclet, Mathieu Gerfaud-Valentin, Cecile-Audrey Durel, Jean-Charles Glerant, Arnaud Hot, François Lestelle, Sabine Mainbourg, Mouhamad Nasser, Pascal Seve, Ségolène Turquier, Gilles Devouassoux, Vincent Cottin
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2024-03-01
Cyfres:Frontiers in Medicine
Pynciau:
Interleukin-5
vasculitis
eosinophil
asthma
corticosteroids
granulomatosis
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fmed.2024.1341310/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fmed.2024.1341310/full

Eitemau Tebyg